Anthropic Raises $65 Billion and Nears $1 Trillion Value
Anthropic just raised $65 billion and is nearing a $1 trillion valuation before it goes public. Most people are reading this as a tech story. It’s actually a wealth transfer story, and the window to understand it clearly is closing fast.
Anthropic’s SpaceX Lease Term Nobody Can Agree On
Anthropic signed a lease with SpaceX and nobody agrees on how long it runs. The debate isn’t just about square footage. It’s a signal about Anthropic’s confidence, its next fundraise, and where the real AI competition is actually playing out.
Karpathy Joins Anthropic and the AI Race Just Changed
Andrej Karpathy just joined Anthropic’s pretraining team, and the enterprise AI market will never be the same. With $450 billion in financial services AI spend up for grabs by 2027, this hire reshuffles every major vendor conversation in fintech. Here’s what smart operators should do before their next contract renewal.
SandboxAQ Puts Drug Discovery AI Inside Claude
SandboxAQ just brought its molecular simulation models into Claude’s AI platform. Biotech founders can now run drug discovery experiments through plain language queries without building expensive computational infrastructure. The incumbents won’t like what comes next.
SandboxAQ Puts Drug Discovery AI Inside Claude
SandboxAQ just plugged its molecular simulation models into Claude, making drug discovery tools accessible without a team of specialists. The average drug costs $2.6 billion to develop. That access barrier just dropped for smaller players.
SandboxAQ Puts Drug Discovery AI Inside Claude
SandboxAQ just made its drug discovery models accessible inside Claude, no specialized computing background required. The average drug costs $2.6 billion to develop. That math is about to change for anyone paying attention. Here’s who wins and who gets left behind.
SandboxAQ Drug Discovery Models Now Live in Claude
SandboxAQ has brought its Large Quantitative Models for molecular simulation into the Claude interface. Drug discovery that once required supercomputers and specialized teams now runs through a browser tab. Here’s what that actually means for pharma, biotech, and anyone paying attention.
SandboxAQ Drug Discovery Comes to Claude Without a PhD
SandboxAQ connected its drug discovery AI to Claude, putting simulation tools that once cost tens of thousands of dollars into any researcher’s browser. The science story is interesting. The money story is bigger. Here’s who wins and who loses.
Anthropic Bought the Dev Tool OpenAI and Google Both Used
Anthropic paid over $500 million for the developer tools startup that OpenAI, Google, and Cloudflare all depended on. The buyer just became the gatekeeper for tools its three biggest rivals cannot easily replace.
Anthropic Now Has More Business Customers Than OpenAI
Ramp spending data shows Anthropic now has more business customers than OpenAI in 2026. While everyone bet on the first mover, businesses quietly ran their own tests and switched. Here’s why it happened and what smart operators should do about it.